Dr McIntyre and colleagues share new insight on how GLP-1 receptor agonists may protect against lithium-induced kidney damage in patients treated for bipolar disorder.

Health Secretary Robert F. Kennedy Jr. is promoting food as medicine, but experts say he’s overstating what diet can do for serious illness ...

A neuroimaging study in Italy found that patients with bipolar disorder reporting more adverse childhood experiences tended ...

More people are dying in the Dallas County jail now than in recent history, and many were likely preventable deaths that ...

Will the lotus bloom or not,” is one of the most discussed political questions raised in Kerala during every election, and the upcoming Assembly polls are no different. For the April 9 Assembly polls, ...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals”, the 'Company”), a clinical-stage biopharmaceutical company, ...

A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.

Brain & Behavior Research Foundation, with Visionary Support from WoodNext Foundation, Awards $1 Million for Breakthrough ...

The National Alliance on Mental Illness highlights mental health struggles through 40 self-portraits at the Sarasota Art ...

The Art of Words Poets' Open Mic event will be held from 5:30-7:45 p.m. Thursday, March. 19, in the meeting room of the Aiken ...

Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...

Rapport Therapeutics, Inc. ( RAPP) Stifel 2026 Virtual CNS Forum March 17, 2026 9:30 AM EDT Great. Good morning, everybody. Happy to be here, moderating this panel with Abe Ceesay, CEO of Rapport ...